Inhaled budesonide for COVID-19 in people at higher risk of complications in the community: the UK National Community Randomi
<p><strong>Background:</strong> The effectiveness of repurposed treatments with supportive evidence for higher risk individuals with COVID-19 in the community is unknown. In the UK PRINCIPLE national platform trial we aimed to determine whether 're-purposed medicines' (hy...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Conference item |
| Language: | English |
| Published: |
Annals of Family Medicine
2023
|